Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference

SOMERVILLE, Mass. , May 28, 2026 /PRNewswire/ -- Generate Biomedicines, Inc. (NASDAQ: GENB) today announced that it intends to participate in the Goldman Sachs Global Healthcare Conference on Monday, June 8, 2026.

A live webcast is expected to be available in the Events and Presentations section of the Company's investor website at investors.generatebiomedicines.com . An archived replay is also expected to be available following the presentation.

About Generate:Biomedicines

Generate (NASDAQ: GENB) is a clinical-stage generative biology company founded at the intersection of machine learning, biological engineering, and medicine, advancing a new era of programmable biology to engineer better medicines for patients, faster. The Generate Platform integrates computational design with large-scale biological experimentation, enabling the creation of novel, optimized therapeutics that address historically undruggable and hard-to-drug targets, as well as known targets in new and more effective ways. The platform has enabled the generation of a broad pipeline of therapies across multiple therapeutic areas and protein-based modalities, addressing health challenges out of reach of traditional approaches. Founded in 2018, Generate is leading a fundamental shift from drug discovery to drug generation. Learn more at www.generatebiomedicines.com, or follow us on X, LinkedIn, and YouTube.

Generate Media Contact

Megan McLaughlin

pr@generatebiomedicines.com

View original content to download multimedia: https://www.prnewswire.com/news-releases/generate-biomedicines-inc-to-participate-in-goldman-sachs-47th-annual-global-healthcare-conference-302785001.html

SOURCE Generate:Biomedicines